|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 04/02/15 | AbbVie : Merck says hepatitis C drugs to lose breakthrough status | RE |
| 10/06/14 | Apple : Wall St. edges up, lifted by mergers, acquisitions | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| -0.73% | +3.67% | +24.31% | +28.60% | +8.25% | +41.38% | -1.04% | +25.98% | +99.59% | 83.96B | |
| +2.84% | +24.49% | +39.63% | +73.86% | -0.84% | -22.44% | -35.85% | -44.07% | +58.96% | 56.76B | |
| +0.85% | -0.32% | +10.60% | +14.71% | -8.91% | -1.93% | +30.25% | +3.00% | - | 51.35B | |
| -0.64% | -1.19% | -9.03% | -9.26% | -9.26% | +10.91% | +165.64% | +118.64% | +196.58% | 48.41B | |
| -1.02% | +4.69% | +10.29% | +17.42% | +25.30% | +58.66% | -16.81% | -35.47% | -30.39% | 32.74B | |
| -19.97% | +129.77% | +145.84% | +203.93% | +395.93% | +443.88% | +31.66% | -61.81% | - | 69.62B | |
| +0.31% | +6.83% | +11.33% | +32.62% | +30.35% | +49.36% | +98.44% | +71.90% | +57.05% | 26.04B | |
| +3.00% | +6.36% | +9.41% | +27.46% | +32.72% | +6.92% | +224.88% | +61.15% | - | 21.81B | |
| -1.25% | +2.45% | -0.73% | +5.32% | +38.10% | +61.72% | +123.98% | +156.26% | +359.14% | 17.11B | |
| -0.01% | +2.14% | +2.71% | +21.59% | +8.45% | +69.70% | +190.03% | +69.18% | - | 16.41B | |
| +1.85% | -4.41% | +42.69% | +7.65% | -12.22% | -7.60% | +793.66% | +529.60% | +6,191.83% | 15.2B | |
| -1.89% | -0.54% | +15.31% | +35.78% | +14.69% | +17.60% | -24.16% | -9.29% | -30.57% | 13.42B | |
| -2.00% | +0.98% | -2.65% | -6.44% | +18.14% | +84.43% | +203.18% | +900.79% | +2,746.57% | 11.43B | |
| -1.37% | +3.77% | +0.44% | +12.80% | +38.19% | +133.58% | +171.33% | +539.22% | - | 10.16B | |
| -2.27% | +10.70% | +58.60% | +158.48% | +337.26% | +424.39% | +615.69% | +38.02% | - | 8.93B | |
| -1.18% | -1.79% | +5.86% | +4.22% | -6.84% | -18.89% | -25.61% | -53.31% | -48.88% | 7.11B | |
| -2.81% | +0.41% | +6.60% | +5.76% | +14.35% | +25.92% | +267.43% | +256.47% | - | 6.25B | |
| -1.90% | -7.77% | +10.78% | +30.12% | +4.60% | +4.66% | +72.15% | -9.96% | - | 6.3B | |
| -1.90% | +2.38% | +27.33% | +46.79% | +93.16% | +139.93% | +362.99% | +553.11% | - | 6.3B | |
| Average | -1.58% | +11.68% | +21.54% | +37.44% | +53.76% | +80.11% | +170.94% | +163.65% | +959.99% | 25.47B | |
| Weighted average by Cap. | -2.67% | +27.74% | +33.56% | +51.40% | +68.13% | +90.83% | +92.96% | +70.32% | +488.86% |
- Stock Market
- Stocks
- Stock
- Sector Idenix Pharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
